Axa S.A. Has $2.49 Million Stock Position in Humana Inc. (NYSE:HUM)

AXA S.A. lessened its stake in Humana Inc. (NYSE:HUM - Free Report) by 22.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 9,797 shares of the insurance provider's stock after selling 2,903 shares during the quarter. AXA S.A.'s holdings in Humana were worth $2,486,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of the company. Transcend Capital Advisors LLC increased its stake in Humana by 399.7% during the 4th quarter. Transcend Capital Advisors LLC now owns 3,643 shares of the insurance provider's stock worth $924,000 after buying an additional 2,914 shares during the period. FNY Investment Advisers LLC increased its position in shares of Humana by 6,647.5% during the fourth quarter. FNY Investment Advisers LLC now owns 27,260 shares of the insurance provider's stock worth $6,916,000 after acquiring an additional 26,856 shares during the last quarter. Retirement Systems of Alabama increased its position in shares of Humana by 735.9% during the fourth quarter. Retirement Systems of Alabama now owns 219,002 shares of the insurance provider's stock worth $55,563,000 after acquiring an additional 192,801 shares during the last quarter. Charles Schwab Investment Management Inc. lifted its stake in shares of Humana by 7.3% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 964,926 shares of the insurance provider's stock worth $244,811,000 after acquiring an additional 65,735 shares in the last quarter. Finally, Secure Asset Management LLC purchased a new position in Humana in the fourth quarter valued at about $244,000. Institutional investors and hedge funds own 92.38% of the company's stock.

Wall Street Analyst Weigh In

HUM has been the topic of a number of recent analyst reports. Oppenheimer upped their target price on Humana from $300.00 to $310.00 and gave the company an "outperform" rating in a research report on Thursday, May 1st. Barclays upped their price target on shares of Humana from $270.00 to $322.00 and gave the company an "equal weight" rating in a report on Friday, April 11th. Robert W. Baird boosted their target price on shares of Humana from $270.00 to $300.00 and gave the stock a "neutral" rating in a research report on Tuesday, April 15th. Cantor Fitzgerald reaffirmed a "neutral" rating and set a $290.00 price target on shares of Humana in a research report on Thursday, May 1st. Finally, JPMorgan Chase & Co. lowered their price objective on Humana from $257.00 to $256.00 and set a "neutral" rating for the company in a report on Tuesday, February 18th. Seventeen analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. According to MarketBeat, Humana presently has a consensus rating of "Hold" and a consensus price target of $287.76.

Humana Stock Performance

HUM traded down $3.68 during trading hours on Friday, hitting $249.67. The company's stock had a trading volume of 1,087,102 shares, compared to its average volume of 1,745,516. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.68. Humana Inc. has a fifty-two week low of $213.31 and a fifty-two week high of $406.46. The company has a 50-day simple moving average of $265.21 and a 200 day simple moving average of $270.38. The firm has a market capitalization of $30.13 billion, a PE ratio of 25.09, a PEG ratio of 2.05 and a beta of 0.49.

Humana (NYSE:HUM - Get Free Report) last announced its earnings results on Wednesday, April 30th. The insurance provider reported $11.58 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $10.07 by $1.51. Humana had a net margin of 1.02% and a return on equity of 11.70%. The firm had revenue of $32.11 billion during the quarter, compared to analyst estimates of $32 billion. During the same quarter in the prior year, the firm posted $7.23 EPS. Humana's revenue was up 8.4% compared to the same quarter last year. As a group, sell-side analysts expect that Humana Inc. will post 16.47 EPS for the current year.

Humana Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, July 25th. Stockholders of record on Friday, June 27th will be given a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a dividend yield of 1.42%. The ex-dividend date of this dividend is Friday, June 27th. Humana's dividend payout ratio (DPR) is presently 25.04%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.